Shortacting nifedipine formulation is not recommended now for treatment of hypertension because:
A. It tends to increase heart rate and cardiac
work
B. It invokes pronounced reflex sympathetic
discharges
C. It can impair haemodynamics in patients
with diastolic dysfunction
D. All of the above
A. It tends to increase heart rate and cardiac
work
B. It invokes pronounced reflex sympathetic
discharges
C. It can impair haemodynamics in patients
with diastolic dysfunction
D. All of the above